DR. DEREK C. WELCH M.D. NPI 1093753303

NPI Information

  • NPI: 1093753303
  • Provider Name: DR. DEREK C. WELCH, M.D.
  • Classification: Pathology - 207ZP0102X
  • Specialization: Anatomic Pathology & Clinical Pathology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1010 AIRPARK CENTER DR
    NASHVILLE, TN
    ZIP 37217
  • Phone: (615) 562-9200

Map and Directions

Get Directions

NPI Details

DR. Derek C. Welch, M.D. is an anatomic pathology and clinical pathology pathology in Nashville, TN with 1 years of experience. The provider is a pathologist deals with the causes and nature of disease and contributes to diagnosis, prognosis and treatment through knowledge gained by the laboratory application of the biologic, chemical and physical sciences. A pathologist uses information gathered from the microscopic examination of tissue specimens, cells and body fluids, and from clinical laboratory tests on body fluids and secretions for the diagnosis, exclusion and monitoring of disease. DR. Derek C. Welch, M.D. NPI is 1093753303. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: ROCKY VISTA UNIVERSITY COLLEGE OF OSTEOPATHIC MED
Graduation Year:2024

The provider's business location address is:

1010 AIRPARK CENTER DR
NASHVILLE, TN
ZIP 37217-200
Phone: (615) 562-9200

The NPI 1093753303 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
  • Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (HCPCS:G0145)
  • Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
  • Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
  • Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
  • Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
  • Detection test by nucleic acid for human papillomavirus (hpv), high-risk types (HCPCS:87624)
  • Detection test for gardnerella vaginalis (bacteria), amplified probe technique (HCPCS:87511)
  • Detection test by nucleic acid for clostridium difficile, amplified probe technique (HCPCS:87493)
  • Pap test, automated thin layer preparation; automated system and manual rescreening (HCPCS:88175)
  • Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
  • Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
  • Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (HCPCS:G0476)
  • Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
  • Detection test by nucleic acid for hepatitis c virus, quantification (HCPCS:87522)
  • Detection test by nucleic acid for herpes simplex virus, amplified probe technique (HCPCS:87529)
  • Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus (HCPCS:87637)
  • Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision (HCPCS:G0123)
  • Detection test by nucleic acid for organism, quantification (HCPCS:87799)
  • Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b (HCPCS:87636)
  • Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
  • Detection test by nucleic acid for hiv-1 virus, quantification (HCPCS:87536)
  • Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
  • Detection test by nucleic acid for human papillomavirus (hpv), types 16 and 18 only (HCPCS:87625)
  • Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
  • Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
  • Detection test by nucleic acid for cytomegalovirus, quantification (HCPCS:87497)
  • Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
  • Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)
  • Detection test by nucleic acid for hepatitis b virus, quantification (HCPCS:87517)
  • Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
  • Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure (HCPCS:88377)
  • Special stained specimen slides to identify organisms including interpretation and report (HCPCS:88312)
  • Microscopic genetic analysis of tumor, manual (HCPCS:88360)
  • Special stained specimen slides to identify organisms including interpretation and report (HCPCS:88312)
  • Biochemical assays for evaluation of chronic hepatitis c virus infection (HCPCS:81596)
  • Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
  • Detection test by nucleic acid for hepatitis c virus, amplified probe technique (HCPCS:87521)
  • Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
  • Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure (HCPCS:88374)
  • Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)
  • Analysis test by nucleic acid for hepatitis c virus (HCPCS:87902)
  • Microscopic genetic analysis of tumor, manual (HCPCS:88360)
  • Cell examination of urine, computer-assisted (HCPCS:88121)
  • Detection of mycoplasma genitalium by dna or rna probe (HCPCS:87563)
  • Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
  • Pap test, manual screening (HCPCS:88142)
  • Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
  • Detection test for candida species (yeast), direct probe technique (HCPCS:87480)
  • Detection test for gardnerella vaginalis (bacteria), direct probe technique (HCPCS:87510)
  • Pathology examination of tissue using a microscope, moderately high complexity (HCPCS:88307)
  • Preparation of specimen, manual (HCPCS:88381)
  • Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician (HCPCS:G0124)
  • Tissue culture for tumor disorders of bone marrow and blood cells (HCPCS:88237)
  • Chromosome analysis for genetic defects, analyze 20-25 cells (HCPCS:88264)
  • Chromosome analysis for genetic defects, additional karyotypes, each study (HCPCS:88280)
  • Preparation of specimen, manual (HCPCS:88381)
  • Preparation of tissue for examination by removing any calcium present (HCPCS:88311)
  • Pathology examination of tissue using a microscope, moderately low complexity (HCPCS:88304)
  • Detection test by nucleic acid for trichomonas vaginalis (genital parasite), direct probe technique (HCPCS:87660)
  • Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure (HCPCS:88377)
  • Pathology examination of tissue using a microscope, moderately low complexity (HCPCS:88304)
  • Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
  • Pathology examination of tissue using a microscope, limited examination (HCPCS:88300)
  • Pathology examination of tissue using a microscope, moderately high complexity (HCPCS:88307)
  • Analysis test by nucleic acid for hiv-1 virus (HCPCS:87901)

The enumeration date for this NPI number is 6/2/2006 and was last updated on 9/2/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207ZP0102XPathologyAnatomic Pathology & Clinical Pathology36584TENNESSEEYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1100049937OTHERTENNESSEEPHP TENNCARE
23332763MEDICAIDTENNESSEE
337819OTHERTENNESSEETLC TENNCARE
44128532OTHERTENNESSEEBLUE SHIELD
5010355915MEDICAIDVIRGINIA
6009938109MEDICAIDALABAMA
7198281OTHERTENNESSEEUNISON TENNCARE
864106099MEDICAIDKENTUCKY

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.